VRPX Stock: What Investors Are Saying About Virpax Pharma as Shares Continue to FlyInvestorPlace • 08/18/21
Virpax's stock rockets nearly 5-fold in 2 days after upbeat FDA response to its SARS-CoV-2 inhibitorMarket Watch • 08/18/21
Virpax soars 292% after receiving initial FDA guidance on its treatment for SARS and fluBusiness Insider • 08/17/21
VRPX Stock: 6 Things for Virpax Pharma Investors to Know as Shares Rocket Over 250%InvestorPlace • 08/17/21
Virpax Pharmaceuticals Reports 2021 Second Quarter Results and Recent DevelopmentsBusiness Wire • 08/10/21
Virpax® Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F.Business Wire • 07/30/21
Virpax to Use Envelta™ IND Enabling Study Results for Two Additional IndicationsBusiness Wire • 06/21/21
Virpax Pharmaceuticals to Present at LD Micro Invitational XI Event on Wednesday, June 9th at 4:30 PM ETBusiness Wire • 06/02/21
Virpax Pharmaceuticals Reports 2021 First Quarter Results and Recent DevelopmentsBusiness Wire • 05/18/21
Virpax Pharmaceuticals Engages Torreya Capital to Advise on Global Partnering EffortsBusiness Wire • 04/22/21
Virpax's Liposomal Bupivacaine Candidate Associated With No Neurotoxicity In Animal StudiesBenzinga • 04/05/21